Graph Therapeutics
Austria - KlosterneuburgBiotechnology
Focus: Graph Therapeutics is an AI-driven drug discovery platform company headquartered in Austria, focused on immunology. The company operates as a public-stage biotech leveraging computational approaches to accelerate therapeutic development.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Graph Therapeutics?
AI assessmentGraph Therapeutics offers early-stage AI-biotech innovation potential, but limited hiring and lack of visible clinical/commercial progress present execution risk for career-stage professionals seeking near-term advancement.
Why Work Here
- Join a publicly-traded AI drug discovery platform with potential for meaningful impact in immunology research
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Graph Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.